Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation

Citation
V. Chesnokova et S. Melmed, Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation, ENDOCRINOL, 141(11), 2000, pp. 4032-4040
Citations number
45
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
ENDOCRINOLOGY
ISSN journal
00137227 → ACNP
Volume
141
Issue
11
Year of publication
2000
Pages
4032 - 4040
Database
ISI
SICI code
0013-7227(200011)141:11<4032:LIFMTH>2.0.ZU;2-W
Abstract
The pleiotropic cytokine leukemia inhibitory factor (LIF) is expressed in m urine hypothalamus and pituitary and increases POMC gene transcription and ACTH secretion in vitro and in vivo. As hypothalamic pituitary adrenal (HPA ) axis activation during inflammation is an important protective mechanism, we determined whether LIF stimulates the HPA inflammatory stress response. Two experimental models were employed: sc injection of complete Freund's a djuvant (CFA) and im administration of turpentine. Hypothalamic LIF gene ex pression was increased up to 5 days after CFA, and up to 24 h after turpent ine. LIF induction was concordant with elevated plasma ACTH and corticoster one levels and pituitary POMC messenger RNA (mRNA) expression. Pituitary le vels of LIF-inducible signaling inhibitor (SOCS 3) mRNA were stimulated S-f old after CFA and turpentine treatment. Tn contrast, in LIF knockout mice ( LIFKO) pituitary POMC mRNA levels and plasma ACTH and corticosterone respon ses to both inflammatory challenges were markedly lower than in wild-type ( WT) animals. Injection of exogenous LIF (5 mug) to turpentine-treeated LIFK O mice induces POMC gene expression. These results indicate that LIF is an essential component for the neuroendocrine response to inflammatory process es.